Applied Digital Just Sent Little-Known Ekso Bionics Stock Soaring. Should You Buy Shares Here?

Core Viewpoint - Ekso Bionics (EKSO) shares surged nearly 100% following Applied Digital's (APLD) announcement of spinning off its cloud segment, which will merge with Ekso to form a new entity called ChronoScale [1]. Group 1: Company Developments - The merger with the spun-off cloud segment is part of a strategic review aimed at unlocking shareholder value for Ekso Bionics [3]. - Ekso Bionics operates in a rapidly expanding market for robotic exoskeletons, which are used for rehabilitation and workplace safety [4]. - Recent healthcare partnerships and industrial deployments have led to a significant revenue growth of 105% sequentially in Q3 [5]. Group 2: Market Position and Valuation - Despite the recent surge, EKSO stock is still down approximately 40% from its year-to-date high [2]. - The price-sales (P/S) multiple for Ekso Bionics is less than 1x, making it an attractive early-stage investment in its market [4]. - The consensus rating for EKSO shares is currently "Moderate Buy," with the highest price target of $9.50 indicating a potential downside of nearly 10% from current levels [7]. Group 3: Technical Analysis - EKSO shares are trading above major moving averages, with a long-term relative strength index (100-day) at nearly 56, suggesting that bullish momentum is still strong [5]. - Investors typically reward companies involved in spinoffs due to anticipated improvements in efficiency and growth prospects [3].